A
Antònia Agustí
Researcher at Autonomous University of Barcelona
Publications - 84
Citations - 1498
Antònia Agustí is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 71 publications receiving 1067 citations. Previous affiliations of Antònia Agustí include Hebron University.
Papers
More filters
Journal ArticleDOI
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Alberto M. Borobia,Antonio J. Carcas,Mayte Pérez-Olmeda,Luis Castaño,María Jesús Bertran,Javier García-Pérez,Magdalena Campins,Antonio Portolés,Maria Gonzalez-Perez,María Teresa García Morales,Eunate Arana-Arri,Marta Aldea,Francisco Díez-Fuertes,Inmaculada Fuentes,Ana Ascaso,David Lora,Natale Imaz-Ayo,Lourdes E Barón-Mira,Antònia Agustí,Carla Pérez-Ingidua,Agustín Gómez de la Cámara,Jose R. Arribas,Jordi Ochando,José Alcamí,Cristobal Belda-Iniesta,Jesús Frías,Lucía Martínez de Soto,Amelia Rodríguez Mariblanca,Lucía Díaz García,Elena Ramírez García,Enrique Seco Meseguer,Stefan Mark Stewart Balbás,Alicia Marín Candón,Irene García García,Mikel Urroz Elizalde,Jaime Monserrat Villatoro,Paula de la Rosa,Marta Sanz García,Cristina López Crespo,Vega Mauleón Martínez,Raquel de Madariaga Castell,Laura Vitón Vara,Julio García Rodríguez,Antonio Buño,Eduardo López Granados,Carmen Camara,Esther Rey Cuevas,Pilar Ayllon García,María Jiménez González,Victoria Hernández Rubio,Paloma Moraga Alapont,Amparo Sánchez,Rocío Prieto,Silvia Gómez,Cristina Miragall Roig,Marina Aparicio Marlasca,Fernando de la Calle,Marta Arsuaga,Blanca Duque,Susana Meijide,Aitor García de Vicuña,Ana Santorcuato,Iraide Expósito,Sara de Benito,Joseba Andia,Cristina Castillo,Esther Irurzun,Jesús Camino,Mikel Temprano,Josune Goikoetxea,Alazne Bustinza,Maialen Larrea,Mikel Gallego,Dolores García-Vázquez,Ana Belén de la Hoz,Gustavo Pérez-Nanclares,Estíbaliz Pérez-Guzmán,Eneko Idoyaga,Adriana Lamela,Jesús Oteo,María Castillo de la Osa,Lourdes Hernández Gutiérrez,María Elena Andrés Galván,Esther Calonge,Mercedes Bermejo,Erick Humberto de la Torre-Tarazona,Almudena Cascajero,Giovanni Fedele,Concepción Perea,Isabel Cervera,Irene Bodega-Mayor,María Montes-Casado,Pilar Portolés,Jana Baranda,Laura Granés,Sulayman Lazaar,Sara Herranz,María Eugènia Mellado,Marta Tortajada,Montserrat Malet,Sebastiana Quesada,Anna Vilella,Anna Llupià,Victoria Olivé,Antoni Trilla,Begoña Gómez,Elisenda González,Sheila Romero,Francisco Javier Gámez,Cristina Casals,Laura Burunat,Juan José Castelló,Patricia Fernández,Josep Lluís Bedini,Jordi Vila,Carla Aguilar,Carmen Altadill,Lluís Armadans,Blanca Borras-Bermejo,Julia Calonge,Lina Camacho,Anna Feliu,Gisela Gili,Cesar Llorente,Xavier Martínez-Gómez,Susana Otero-Romero,Esther Palacio,Oleguer Parés,Laia Pinós,Aitana Plaza,Judith Riera,José Angel Rodrigo-Pendás,Carla Sans,J. Santos,Gloria Torres,Margarita Torrens,Sonia Uriona,Elena Ballarin Alins,Eulàlia Pérez Esquirol,Lourdes Vendrell Bosch,Leonor Laredo Velasco,Diana Uribe López,Esperanza González Rojano,Manuel Sánchez-Craviotto,Ana Belén Rivas Paterna,Teresa Iglesias Hernán-Gómez,Natalia Rodríguez Galán,José Antonio Gil Marín,Verónica Álvarez-Morales,Ana Belén Navalpotro,M Dolores Jiménez-Santamaría,M Carmen Cardós,Elena Hermoso,Mar García-Arenillas,Natalia Pérez Macías,Alexandra Domingo Fernández,Amanda López Picado,Jorge Mario Quiñones,Nicoletta Deidda,Ana García-Franco,José María Torvisco +160 more
TL;DR: In this paper, the authors assessed the immunogenicity and reactogenicity of BNT162b2 (Comirnaty, BioNTech, Mainz, Germany) administered as second dose in participants primed with ChAdOx1-S (Vaxzevria, AstraZeneca, Oxford, UK).
Journal ArticleDOI
Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.
Antonio Vallano,Gloria Cereza,Consuelo Pedrós,Antònia Agustí,Immaculada Danés,Cristina Aguilera,J. M. Arnau +6 more
TL;DR: The perception of the different obstacles by the hospital physicians is an important factor in determining the causes of the underreporting of ADRs and addressing these obstacles could lead to an improvement in spontaneous reporting.
Journal ArticleDOI
β-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials
Sara Bonet,Antònia Agustí,Josep Maria Arnau,Xavier Vidal,Eduard Diogène,Enrique Galve,Joan-Ramon Laporte +6 more
TL;DR: In patients with heart failure, b-blockers reduce total and cardiovascular mortality at the expense of a decrease in mortality due to pump failure and sudden death, similar in patients with IHD and in those with non-IHD.
Journal ArticleDOI
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.
TL;DR: In order to classify a cell- or a tissue-based product as an advanced therapy, it must be ensured that the processing of the cells implies a manipulation that alters their biological characteristics, although the term of manipulation in US differentiates between structural and non-structural cells and tissues.
Journal ArticleDOI
Inappropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors
Antonio San-José,Antònia Agustí,Xavier Vidal,Francesc Formiga,Mercedes Gómez-Hernández,Juana García,Alfonso López-Soto,Nieves Ramírez-Duque,Olga H. Torres,José Barbé +9 more
TL;DR: Benzodiazepine use in those who are prone to falls and omission of calcium and vitamin D in those with osteoporosis were the most frequent PIM and PPO, respectively, with polypharmacy being the most important factor associated with PIM.